|
2014-12-08 |
2014-12-05 |
V
Verkauf
|
Lurker Nancy
Nicht geschäftsführender Verwaltungsratsmitglied
|
7.430
-42.6%
34,00
252.620 USD
|
7.430
-42.6%
|
34,00
|
252.620 USD
|
|
|
2014-12-08 |
2014-12-05 |
V
Verkauf
|
Lurker Nancy
Nicht geschäftsführender Verwaltungsratsmitglied
|
25.000
-58.9%
34,00
850.000 USD
|
25.000
-58.9%
|
34,00
|
850.000 USD
|
|
|
2014-12-08 |
2014-12-05 |
V
Verkauf
|
MCKEE WILLIAM
Nicht geschäftsführender Verwaltungsratsmitglied
|
18.000
-64.3%
34,00
612.000 USD
|
18.000
-64.3%
|
34,00
|
612.000 USD
|
|
|
2014-12-08 |
2014-12-05 |
V
Verkauf
|
ADAMS ADRIAN
CEO and President
Geschäftsführender Verwaltungsratsmitglied
|
40.000
-15.5%
33,97
1.358.704 USD
|
40.000
-15.5%
|
33,97
|
1.358.704 USD
|
|
|
2014-12-08 |
2014-12-05 |
V
Verkauf
|
FRIEDMAN PAUL A
Nicht geschäftsführender Verwaltungsratsmitglied
|
9.689
-48.3%
33,85
327.953 USD
|
9.689
-48.3%
|
33,85
|
327.953 USD
|
|
|
2014-12-08 |
2014-12-04 |
V
Verkauf
|
FRIEDMAN PAUL A
Nicht geschäftsführender Verwaltungsratsmitglied
|
20.000
-49.9%
33,67
673.452 USD
|
20.000
-49.9%
|
33,67
|
673.452 USD
|
|
|
2014-12-04 |
2014-12-03 |
V
Verkauf
|
FETZER OLIVER
Nicht geschäftsführender Verwaltungsratsmitglied
|
50.000
-72.3%
34,00
1.700.000 USD
|
50.000
-72.3%
|
34,00
|
1.700.000 USD
|
|
|
2014-12-04 |
2014-12-02 |
V
Verkauf
|
CLASSON ROLF A
Nicht geschäftsführender Verwaltungsratsmitglied
|
19.135
-65.7%
33,75
645.726 USD
|
19.135
-65.7%
|
33,75
|
645.726 USD
|
|
|
2014-12-04 |
2014-12-02 |
V
Verkauf
|
CLASSON ROLF A
Nicht geschäftsführender Verwaltungsratsmitglied
|
260.000
-89.9%
33,81
8.790.808 USD
|
260.000
-89.9%
|
33,81
|
8.790.808 USD
|
|
|
2014-12-04 |
2014-12-02 |
V
Verkauf
|
FETZER OLIVER
Nicht geschäftsführender Verwaltungsratsmitglied
|
50.000
-72.3%
34,03
1.701.635 USD
|
50.000
-72.3%
|
34,03
|
1.701.635 USD
|
|
|
2014-11-26 |
2014-11-25 |
V
Verkauf
|
JOBES ELIZABETH VARKI
Chief Compliance Officer
Führungsperson
|
23.750
-63.3%
34,03
808.310 USD
|
23.750
-63.3%
|
34,03
|
808.310 USD
|
|
|
2014-11-26 |
2014-11-25 |
V
Verkauf
|
JOBES ELIZABETH VARKI
Chief Compliance Officer
Führungsperson
|
4.052
-9.7%
34,05
137.964 USD
|
4.052
-9.7%
|
34,05
|
137.964 USD
|
|
|
2014-11-26 |
2014-11-25 |
V
Verkauf
|
Tursi James Patrick
Chief Medical Officer
Führungsperson
|
3.151
-9.0%
34,13
107.534 USD
|
3.151
-9.0%
|
34,13
|
107.534 USD
|
|
|
2014-11-26 |
2014-11-25 |
V
Verkauf
|
Tursi James Patrick
Chief Medical Officer
Führungsperson
|
10.562
-23.2%
34,12
360.394 USD
|
10.562
-23.2%
|
34,12
|
360.394 USD
|
|
|
2014-11-24 |
2014-11-21 |
V
Verkauf
|
KOVEN ANDREW I
EVP, CAO, GC and Secretary
Führungsperson
|
134.375
-77.6%
33,43
4.492.412 USD
|
134.375
-77.6%
|
33,43
|
4.492.412 USD
|
|
|
2014-11-24 |
2014-11-21 |
V
Verkauf
|
KOVEN ANDREW I
EVP, CAO, GC and Secretary
Führungsperson
|
5.308
-3.0%
33,44
177.518 USD
|
5.308
-3.0%
|
33,44
|
177.518 USD
|
|
|
2014-11-24 |
2014-11-21 |
V
Verkauf
|
Armstrong Jennifer Lou
Senior Vice President, HR
Führungsperson
|
69.412
-82.4%
33,50
2.325.031 USD
|
69.412
-82.4%
|
33,50
|
2.325.031 USD
|
|
|
2014-11-24 |
2014-11-21 |
V
Verkauf
|
Armstrong Jennifer Lou
Senior Vice President, HR
Führungsperson
|
6.391
-7.0%
33,50
214.075 USD
|
6.391
-7.0%
|
33,50
|
214.075 USD
|
|
|
2014-11-24 |
2014-11-21 |
V
Verkauf
|
Tursi James Patrick
Chief Medical Officer
Führungsperson
|
5.000
-12.5%
33,49
167.432 USD
|
5.000
-12.5%
|
33,49
|
167.432 USD
|
|
|
2014-11-24 |
2014-11-21 |
V
Verkauf
|
Tursi James Patrick
Chief Medical Officer
Führungsperson
|
3.648
-8.3%
33,45
122.011 USD
|
3.648
-8.3%
|
33,45
|
122.011 USD
|
|
|
2014-11-24 |
2014-11-20 |
V
Verkauf
|
WILLS ALAN
EVP, Corporate Development
Führungsperson
|
13.717
-30.9%
33,18
455.086 USD
|
13.717
-30.9%
|
33,18
|
455.086 USD
|
|
|
2014-11-24 |
2014-11-20 |
V
Verkauf
|
WILLS ALAN
EVP, Corporate Development
Führungsperson
|
142.875
-76.3%
33,18
4.740.207 USD
|
142.875
-76.3%
|
33,18
|
4.740.207 USD
|
|
|
2014-11-24 |
2014-11-20 |
V
Verkauf
|
Glickman Mark A
EVP - Sales and Marketing
Führungsperson
|
40.750
-59.3%
33,16
1.351.372 USD
|
40.750
-59.3%
|
33,16
|
1.351.372 USD
|
|
|
2014-11-24 |
2014-11-20 |
V
Verkauf
|
Glickman Mark A
EVP - Sales and Marketing
Führungsperson
|
7.202
-9.5%
33,18
238.963 USD
|
7.202
-9.5%
|
33,18
|
238.963 USD
|
|
|
2014-11-24 |
2014-11-20 |
V
Verkauf
|
Tursi James Patrick
Chief Medical Officer
Führungsperson
|
59.800
-57.8%
33,18
1.983.871 USD
|
59.800
-57.8%
|
33,18
|
1.983.871 USD
|
|
|
2014-11-24 |
2014-11-20 |
V
Verkauf
|
Tursi James Patrick
Chief Medical Officer
Führungsperson
|
6.200
-5.7%
32,94
204.253 USD
|
6.200
-5.7%
|
32,94
|
204.253 USD
|
|
|
2014-03-17 |
2014-03-14 |
V
Verkauf
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Führungsperson
|
524
-8.3%
29,55
15.484 USD
|
524
-8.3%
|
29,55
|
15.484 USD
|
|
|
2014-03-17 |
2014-03-14 |
V
Verkauf
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Führungsperson
|
883
-12.3%
29,55
26.093 USD
|
883
-12.3%
|
29,55
|
26.093 USD
|
|
|
2014-03-17 |
2014-03-14 |
V
Verkauf
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Führungsperson
|
30.625
-57.4%
29,50
903.438 USD
|
30.625
-57.4%
|
29,50
|
903.438 USD
|
|
|
2014-03-06 |
2014-03-05 |
V
Verkauf
|
CLASSON ROLF A
Nicht geschäftsführender Verwaltungsratsmitglied
|
10.000
-30.4%
31,85
318.477 USD
|
10.000
-30.4%
|
31,85
|
318.477 USD
|
|
|
2013-12-16 |
2013-12-13 |
GV
Geplanter Verkauf
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Führungsperson
|
302
-6.9%
20,50
6.191 USD
|
302
-6.9%
|
20,50
|
6.191 USD
|
|
|
2013-12-16 |
2013-12-13 |
V
Verkauf
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Führungsperson
|
4.300
-49.6%
20,50
88.150 USD
|
4.300
-49.6%
|
20,50
|
88.150 USD
|
|
|
2013-12-12 |
2013-12-11 |
GV
Geplanter Verkauf
|
Fickenscher James E
Chief Financial Officer
Führungsperson
|
71.067
-61.2%
20,37
1.447.450 USD
|
71.067
-61.2%
|
20,37
|
1.447.450 USD
|
|
|
2013-05-22 |
2013-05-20 |
V
Verkauf
|
MCKEE WILLIAM
Nicht geschäftsführender Verwaltungsratsmitglied
|
2.000
-20.0%
15,10
30.209 USD
|
2.000
-20.0%
|
15,10
|
30.209 USD
|
|
|
2012-06-26 |
2012-06-25 |
GV
Geplanter Verkauf
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Führungsperson
|
12.682
-73.9%
25,01
317.155 USD
|
12.682
-73.9%
|
25,01
|
317.155 USD
|
|
|
2012-06-08 |
2012-06-06 |
V
Verkauf
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Führungsperson
|
5.700
-73.8%
22,55
128.536 USD
|
5.700
-73.8%
|
22,55
|
128.536 USD
|
|
|
2012-06-08 |
2012-06-06 |
V
Verkauf
|
DEL TITO BENJAMIN J JR
EVP, Reg Affairs & Project Mgt
Führungsperson
|
300
-3.7%
22,55
6.766 USD
|
300
-3.7%
|
22,55
|
6.766 USD
|
|
|
2012-03-01 |
2012-02-28 |
K
Kauf
|
Brandt Peter C.
Nicht geschäftsführender Verwaltungsratsmitglied
|
9.700
+3233.3%
20,10
194.970 USD
|
9.700
+3233.3%
|
20,10
|
194.970 USD
|
|
|
2012-03-01 |
2012-02-28 |
K
Kauf
|
Brandt Peter C.
Nicht geschäftsführender Verwaltungsratsmitglied
|
300
+inf%
20,09
6.028 USD
|
300
+inf%
|
20,09
|
6.028 USD
|
|
|
2011-11-07 |
2011-11-03 |
K
Kauf
|
Fickenscher James E
Chief Financial Officer
Führungsperson
|
1.610
+6.4%
15,54
25.024 USD
|
1.610
+6.4%
|
15,54
|
25.024 USD
|
|
|
2011-10-11 |
2011-10-07 |
GV
Geplanter Verkauf
|
ANIDO ARMANDO
CEO & President
Geschäftsführender Verwaltungsratsmitglied
|
5.275
-27.9%
14,23
75.046 USD
|
5.275
-27.9%
|
14,23
|
75.046 USD
|
|
|
2011-08-03 |
2011-08-02 |
V
Verkauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
40.781
-0.7%
17,25
703.391 USD
|
40.781
-0.7%
|
17,25
|
703.391 USD
|
|
|
2011-08-03 |
2011-08-02 |
V
Verkauf
|
14159 capital (GP), LLC
Large shareholder
|
1.001
-0.7%
17,25
17.265 USD
|
1.001
-0.7%
|
17,25
|
17.265 USD
|
|
|
2011-08-03 |
2011-08-02 |
V
Verkauf
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
507
-0.7%
17,25
8.745 USD
|
507
-0.7%
|
17,25
|
8.745 USD
|
|
|
2011-08-03 |
2011-08-02 |
V
Verkauf
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
6.361
-0.7%
17,25
109.715 USD
|
6.361
-0.7%
|
17,25
|
109.715 USD
|
|
|
2011-08-03 |
2011-08-01 |
V
Verkauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
394.404
-6.7%
18,04
7.114.614 USD
|
394.404
-6.7%
|
18,04
|
7.114.614 USD
|
|
|
2011-08-03 |
2011-08-01 |
V
Verkauf
|
14159 capital (GP), LLC
Large shareholder
|
9.678
-6.7%
18,04
174.580 USD
|
9.678
-6.7%
|
18,04
|
174.580 USD
|
|
|
2011-08-03 |
2011-08-01 |
V
Verkauf
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
4.902
-6.7%
18,04
88.427 USD
|
4.902
-6.7%
|
18,04
|
88.427 USD
|
|
|
2011-08-03 |
2011-08-01 |
V
Verkauf
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
61.519
-6.7%
18,04
1.109.735 USD
|
61.519
-6.7%
|
18,04
|
1.109.735 USD
|
|
|
2011-08-03 |
2011-08-01 |
V
Verkauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
260.868
-4.3%
18,03
4.703.320 USD
|
260.868
-4.3%
|
18,03
|
4.703.320 USD
|
|
|
2011-08-03 |
2011-08-01 |
V
Verkauf
|
14159 capital (GP), LLC
Large shareholder
|
6.400
-4.3%
18,03
115.389 USD
|
6.400
-4.3%
|
18,03
|
115.389 USD
|
|
|
2011-08-03 |
2011-08-01 |
V
Verkauf
|
Baker / Tisch Capital (GP), LLC
Large shareholder
|
3.243
-4.3%
18,03
58.470 USD
|
3.243
-4.3%
|
18,03
|
58.470 USD
|
|
|
2011-08-03 |
2011-08-01 |
V
Verkauf
|
Baker Biotech Capital (GP), LLC
Large shareholder
|
40.690
-4.3%
18,03
733.620 USD
|
40.690
-4.3%
|
18,03
|
733.620 USD
|
|
|
2011-07-12 |
2011-07-08 |
GV
Geplanter Verkauf
|
ANIDO ARMANDO
CEO & President
Geschäftsführender Verwaltungsratsmitglied
|
5.275
-27.9%
20,30
107.101 USD
|
5.275
-27.9%
|
20,30
|
107.101 USD
|
|
|
2011-03-31 |
2011-03-30 |
K
Kauf
|
14159 capital (GP), LLC
Large shareholder
|
3.911
+2.7%
21,98
85.963 USD
|
3.911
+2.7%
|
21,98
|
85.963 USD
|
|
|
2011-03-31 |
2011-03-30 |
K
Kauf
|
Baker Bros. Capital (GP), LLC
Large shareholder
|
309
+4.6%
21,98
6.792 USD
|
309
+4.6%
|
21,98
|
6.792 USD
|
|
|
2011-03-31 |
2011-03-29 |
K
Kauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
82.000
+1.4%
21,94
1.798.670 USD
|
82.000
+1.4%
|
21,94
|
1.798.670 USD
|
|
|
2011-03-31 |
2011-03-29 |
K
Kauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
250.000
+4.3%
22,00
5.499.400 USD
|
250.000
+4.3%
|
22,00
|
5.499.400 USD
|
|
|
2011-03-10 |
2011-03-09 |
K
Kauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
550.000
+10.5%
22,75
12.513.765 USD
|
550.000
+10.5%
|
22,75
|
12.513.765 USD
|
|
|
2011-03-10 |
2011-03-09 |
K
Kauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
115.000
+2.3%
23,44
2.695.060 USD
|
115.000
+2.3%
|
23,44
|
2.695.060 USD
|
|
|
2011-03-10 |
2011-03-09 |
K
Kauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
117.273
+2.3%
23,17
2.717.344 USD
|
117.273
+2.3%
|
23,17
|
2.717.344 USD
|
|
|
2011-03-10 |
2011-03-08 |
K
Kauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
58.388
+1.2%
22,81
1.331.976 USD
|
58.388
+1.2%
|
22,81
|
1.331.976 USD
|
|
|
2011-03-10 |
2011-03-08 |
K
Kauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
1.948
+0.0%
22,51
43.845 USD
|
1.948
+0.0%
|
22,51
|
43.845 USD
|
|
|
2011-03-10 |
2011-03-08 |
K
Kauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
48.657
+1.0%
22,86
1.112.299 USD
|
48.657
+1.0%
|
22,86
|
1.112.299 USD
|
|
|
2011-03-10 |
2011-03-08 |
K
Kauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
86.227
+1.8%
22,88
1.972.693 USD
|
86.227
+1.8%
|
22,88
|
1.972.693 USD
|
|
|
2011-03-10 |
2011-03-08 |
K
Kauf
|
14159 capital (GP), LLC
Large shareholder
|
1.612
+1.1%
22,81
36.774 USD
|
1.612
+1.1%
|
22,81
|
36.774 USD
|
|
|
2011-03-10 |
2011-03-08 |
K
Kauf
|
14159 capital (GP), LLC
Large shareholder
|
54
+0.0%
22,51
1.215 USD
|
54
+0.0%
|
22,51
|
1.215 USD
|
|
|
2011-03-10 |
2011-03-08 |
K
Kauf
|
14159 capital (GP), LLC
Large shareholder
|
1.343
+0.9%
22,86
30.701 USD
|
1.343
+0.9%
|
22,86
|
30.701 USD
|
|
|
2011-03-10 |
2011-03-08 |
K
Kauf
|
14159 capital (GP), LLC
Large shareholder
|
2.380
+1.7%
22,88
54.449 USD
|
2.380
+1.7%
|
22,88
|
54.449 USD
|
|
|
2011-03-10 |
2011-03-08 |
K
Kauf
|
Baker Brothers Life Sciences Capital (GP), LLC
Large shareholder
|
10.996
+0.2%
23,05
253.503 USD
|
10.996
+0.2%
|
23,05
|
253.503 USD
|
|
|
2011-03-10 |
2011-03-08 |
K
Kauf
|
14159 capital (GP), LLC
Large shareholder
|
304
+0.2%
23,05
7.008 USD
|
304
+0.2%
|
23,05
|
7.008 USD
|
|
|
2011-03-09 |
2011-03-08 |
GV
Geplanter Verkauf
|
ANIDO ARMANDO
CEO & President
Geschäftsführender Verwaltungsratsmitglied
|
5.275
-24.7%
23,03
121.502 USD
|
5.275
-24.7%
|
23,03
|
121.502 USD
|
|
|
2011-03-09 |
2011-03-08 |
GV
Geplanter Verkauf
|
ANIDO ARMANDO
CEO & President
Geschäftsführender Verwaltungsratsmitglied
|
5.280
-24.7%
23,01
121.492 USD
|
5.280
-24.7%
|
23,01
|
121.492 USD
|
|
|
2011-01-12 |
2011-01-10 |
GV
Geplanter Verkauf
|
ANIDO ARMANDO
CEO & President
Geschäftsführender Verwaltungsratsmitglied
|
5.275
-24.7%
23,27
122.723 USD
|
5.275
-24.7%
|
23,27
|
122.723 USD
|
|
|
2011-01-12 |
2011-01-10 |
GV
Geplanter Verkauf
|
ANIDO ARMANDO
CEO & President
Geschäftsführender Verwaltungsratsmitglied
|
5.280
-24.7%
23,17
122.327 USD
|
5.280
-24.7%
|
23,17
|
122.327 USD
|
|
